ZNF19, or zinc finger protein 19, is one of the many proteins in the human body encoded by the ZNF19 gene. Characterized by the presence of zinc finger domains, ZNF19 is part of a large family of transcription factors that play a critical role in gene expression, DNA recognition, RNA packaging, and the regulation of apoptosis. The presence of the zinc finger motif, a type of protein domain that can bind to DNA, suggests that ZNF19 may be intricately involved in the transcriptional regulation of various genes. Found in several tissues with notably higher expression in the testis and thyroid, ZNF19's function, while not fully elucidated, is believed to be associated with the intricate orchestration of developmental processes and maintenance of cellular functions. The gene's location on chromosome 16 positions it in close proximity to ZNF23, another member of the zinc finger protein family, which may indicate a shared regulatory pathway or functional similarities.
The expression of ZNF19 could potentially be influenced by a range of chemical activators, which, upon exposure, might stimulate or upregulate its activity. Such chemicals exert their effects through diverse mechanisms, including but not limited to epigenetic modifications and signaling pathway modulations. For instance, molecules like retinoic acid can activate gene expression by binding to nuclear receptors that, in turn, bind to DNA response elements associated with genes like ZNF19. On the other hand, compounds such as 5-Azacytidine or Trichostatin A can alter the epigenetic landscape, either by DNA demethylation or by changing the acetylation status of histones, respectively, promoting a transcriptionally active chromatin state at the ZNF19 gene locus. Activation can also occur through signal transduction pathways, where agents like Forskolin or Lithium Chloride increase intracellular signaling molecules, subsequently affecting transcription factor activity that can lead to enhanced expression of ZNF19. Hence, while the precise regulatory mechanisms of ZNF19 are yet to be fully understood, these chemicals represent potential activators that could, through various biochemical pathways, upregulate the expression of this zinc finger protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may upregulate ZNF19 expression by activating retinoic acid receptors that bind to retinoic acid response elements in the promoter regions of target genes, including potentially ZNF19. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By causing DNA demethylation, 5-Azacytidine could result in the reactivation of ZNF19 expression if methylation is suppressing the ZNF19 promoter region. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may stimulate ZNF19 transcription by preventing the deacetylation of histones, resulting in a more accessible chromatin configuration at the ZNF19 locus. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin could potentially increase ZNF19 expression by elevating intracellular cAMP, thereby activating protein kinase A (PKA) and subsequent transcription factor binding to ZNF19 promoter sequences. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate could induce ZNF19 by increasing histone acetylation levels, thereby promoting transcriptional activation of ZNF19 through enhanced accessibility of transcriptional machinery. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol may stimulate the expression of ZNF19 by estrogen receptor-mediated recruitment of coactivators to estrogen response elements that could be associated with ZNF19 regulatory regions. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone could upregulate ZNF19 through glucocorticoid receptor interaction, leading to the binding of the receptor complex to glucocorticoid response elements in the ZNF19 promoter. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may stimulate ZNF19 expression through the inhibition of GSK-3β, resulting in the activation of β-catenin signaling which can lead to upregulation of target gene transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA could increase ZNF19 expression by activating protein kinase C (PKC), which may then enhance transcription factor activity that promotes ZNF19 gene transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate may induce ZNF19 expression by inhibiting DNA methyltransferases, potentially reversing methylation silencing of the ZNF19 gene. |